Research Calls
-
Upgrades:
- ARS Pharmaceuticals (SPRY) upgraded to Outperform from Market Perform at Leerink Partners; tgt raised to $18
- AT&T (T) upgraded to Outperform from Peer Perform at Wolfe Research; tgt $21
- BARK Inc. (BARK) upgraded to Buy from Hold at Jefferies; tgt raised to $1.90
- Cable ONE (CABO) upgraded to Buy from Neutral at MoffettNathanson; tgt $615
- Lyft (LYFT) upgraded to Buy from Hold at Argus
- ONE Gas (OGS) upgraded to Buy from Neutral at Ladenburg Thalmann; tgt $64.50
- Sea Limited (SE) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $70
-
Downgrades:
- BHP Group (BHP) downgraded to Hold from Buy at Liberum
- Chemours (CC) downgraded to Neutral from Buy at UBS; tgt lowered to $21
- Genesco (GCO) downgraded to Neutral from Buy at B. Riley Securities; tgt lowered to $31
- GlobalFoundries (GFS) downgraded to Neutral from Positive at Susquehanna; tgt $48
- Philip Morris International (PM) downgraded to Hold from Buy at Argus
- Rio Tinto (RIO) downgraded to Hold from Buy at Liberum
- Williams-Sonoma (WSM) downgraded to Hold from Buy at Loop Capital; tgt raised to $220
-
Others:
- Amphastar Pharmaceuticals (AMPH) initiated with an Overweight at JP Morgan; tgt $60
- Array Tech (ARRY) initiated with a Sector Weight at KeyBanc Capital Markets
- BBB Foods (TBBB) initiated with an Equal-Weight at Morgan Stanley; tgt $22
- BBB Foods (TBBB) initiated with a Buy at BofA Securities; tgt $26
- Installed Building Products (IBP) initiated with a Buy at DA Davidson; tgt $275
- Metagenomi (MGX) initiated with an Overweight at Wells Fargo; tgt $25
- Metagenomi (MGX) initiated with a Buy at Chardan Capital Markets; tgt $21
- Metagenomi (MGX) initiated with a Buy at Jefferies; tgt $23
- Metagenomi (MGX) initiated with an Overweight at JP Morgan; tgt $16
- Metagenomi (MGX) initiated with an Outperform at BMO Capital Markets; tgt $22
- TopBuild (BLD) initiated with a Buy at DA Davidson; tgt $470
- Zealand Pharma (ZEAL) initiated with a Buy at Berenberg